Xeris Pharmaceuticals | XERS - Себестоимость





Себестоимость Изменить Дата
Celltrion KRW 92.83B 14.59B 2026-03
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 11.19B 1.2B 2026-06
Eli Lilly USD 3.27B 309M 2026-06
Kangmei Pharma CNY 961.15M 119.7M 2026-06
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Medical Developments International AUD 7.09M 4.91M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pacira USD 58.49M 7.75M 2026-06
Perrigo USD 708.9M 65.2M 2026-06
Pharma Mar EUR 4.73M 1.08M 2026-06
Qiagen NV USD 196.45M 13.73M 2026-06
Sartorius EUR 478.7M 5.9M 2026-06
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Supernus Pharmaceuticals USD 59M 9.97M 2026-06
Tilray USD 164.37M 8.41M 2025-09
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.17B 418.33M 2026-06